ACHILLION PHARMACEUTICALS, INC… (NASDAQ:ACHN) - Page 2

generic drugs

Achillion Pharma Rises on Solid Interim Results

Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) is making up for lost time with its most recent news. Over the course of 2015 and last year, the stock has suffered, but it ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Amgen, Dow, Fitbit, Office Depot, SanDisk, Wells Fargo, Yum and Many More

Stocks were indicated substantially higher on Tuesday morning after the Labor Day weekend. China shares were higher, as was Europe. The trend of buying pullbacks lives on. 24/7 Wall St. ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Achillion, CSC, Keurig, Sarepta, Splunk and More

Stocks were marginally higher on Wednesday morning, but the S&P 500 and DJIA are effectively at all-time highs. As investors keep proving over and over that they want to buy ...
Read Full Story »
research

Analyst Issues 5 Potential Biotech Buyout Candidates

We have said it before, and we will stress it once again, one of the best ways for big pharmaceuticals and biotech companies to grow is through acquisitions. In a ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Alcoa, Apache, Bob Evans, F5 Networks, McDonald’s and More

Stocks were indicated marginally lower again on Wednesday after hitting new highs last week and after the Nasdaq hit 5,000 for the first time in 15 years. The one trend ...
Read Full Story »
buy sell

5 Big After-Hours Movers on Tuesday

24/7 Wall St. has tracked several stocks with key moves in the after-hours trading session on Tuesday. Some of these might not merit a full blown review on their own, ...
Read Full Story »
biotech

Achillion Breaks Through Phase 2 HCV

Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) announced updated interim results from its ongoing interferon-free, ribavirin-free Phase 2 study evaluating ACH-3102 and sofosbuvir. Sofosbuvir is a marketed nucleotide polymerase inhibitor. Ultimately the ...
Read Full Story »
upgrade

Top Analyst Upgrades and Downgrades: Baker Hughes, CryoLife, Halliburton, Nabors, Red Hat, Sonus and More

Stocks were indicated higher yet again on Tuesday, with the Dow Jones Industrial Average in striking distance of 18,000. Investors have shown over and over that they will buy stocks ...
Read Full Story »
biotech

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

One sad trend that has exploded in the new millennium has been the increase in hepatitis C cases in the Unites States and around the world. One startling fact is ...
Read Full Story »
buy sell

Insider Selling Jumps as Market Volatility Highest Since Summer

The good day on Friday notwithstanding, market volatility jumped this past week to the highest level in almost two months. The volatility indicator, or VIX as it is known, declined ...
Read Full Story »
health care

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

For a variety of reasons, the cases of chronic hepatitis in the United States have surged dramatically over the past 20 years. Currently, it is estimated that more than 3.2 ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Achillion, GE, Monster, Newmont, SeaWorld and More

Stocks were firm on Monday morning after a very volatile Friday. It appears as though many investors have used the recent weakness and volatility to accumulate some of the stocks ...
Read Full Story »
ten dollars

10 Analyst Stocks to Buy Under $10 With Massive Upside Calls

Stocks had a crazy end to the week on reports of tension escalation and fighting in Ukraine and Russia. Still, investors are looking to use market weakness to find bargain ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Achillion, Monster, Gilead, JCPenney, JDSU, Green Mountain and More

Stocks were firm yet again on Friday morning ahead of the PPI wholesale inflation report. Investors have been trying to decide where to put their money after the recent stock ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Achillion, Gap, GNC, King Digital, Pepsi, Tesla and More

Stocks were firm on Monday morning, looking to add to the recovery bounce from Friday. Investors have now been given an opportunity to look for stocks that have pulled back ...
Read Full Story »